Importantly, the benefit of GLP-1 receptor agonists injected weekly was also shown to be the same as that of agents injected daily, the researchers wrote
You can always opt-out of receiving marketing emails by using the opt-out feature provided with the email communications
Nordexa Research does not provide preparation instructions, reconstitution guidance, administration guidance, dosing information, protocols, or medical advice
Tirzepatide exposure increases proportionally across the entire dose range from 0.25 mg to 15 mg
To date, cardiovascular outcome studies show that GLP-1 receptor (GLP-1R) agonists reduce atherosclerotic events including myocardial infarction and stroke, and also prevent progression of chronic kidney disease in type-2 diabetic patients [3,4,5]